ULY vs. BIAF

Last updated Apr 1, 2026

Compare and contrast key facts about Urgent.ly Inc. Common Stock (ULY) and bioAffinity Technologies Inc. (BIAF).

Performance

ULY vs. BIAF - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Urgent.ly Inc. Common Stock (ULY) and bioAffinity Technologies Inc. (BIAF). The values are adjusted to include any dividend payments, if applicable.

ULY vs. BIAF - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023
ULY Urgent.ly Inc. Common Stock	84.25%	-52.29%	-83.91%	-44.47%
BIAF bioAffinity Technologies Inc.	224.58%	-95.68%	-38.12%	8.93%

Fundamentals

EPS ULY : -$13.78 BIAF : -$15.79
PS Ratio ULY : 0.06 BIAF : 0.53
Total Revenue (TTM) ULY : $129.19M BIAF : $6.78M
Gross Profit (TTM) ULY : $31.48M BIAF : $1.62M
EBITDA (TTM) ULY : -$4.02M BIAF : -$14.11M

Returns By Period

In the year-to-date period, ULY achieves a 84.25% return, which is significantly lower than BIAF's 224.58% return.

ULY

• 1D: 0.00%
• 1M: 177.32%
• YTD: 84.25%
• 6M: 66.56%
• 1Y: 15.20%
• 3Y*: —
• 5Y*: —
• 10Y*: —

BIAF

• 1D: 8.19%
• 1M: 261.32%
• YTD: 224.58%
• 6M: 29.39%
• 1Y: -50.90%
• 3Y*: -59.27%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

ULY vs. BIAF — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ULY

ULY Risk / Return Rank: 59
ULY Sharpe Ratio Rank: 43
ULY Sortino Ratio Rank: 85
ULY Omega Ratio Rank: 80
ULY Calmar Ratio Rank: 44
ULY Martin Ratio Rank: 43

BIAF

BIAF Risk / Return Rank: 52
BIAF Sharpe Ratio Rank: 34
BIAF Sortino Ratio Rank: 87
BIAF Omega Ratio Rank: 83
BIAF Calmar Ratio Rank: 24
BIAF Martin Ratio Rank: 31

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ULY vs. BIAF - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Urgent.ly Inc. Common Stock (ULY) and bioAffinity Technologies Inc. (BIAF). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	ULY	BIAF	Difference
Sharpe ratio Return per unit of total volatility	0.06	-0.13	+0.20
Sortino ratio Return per unit of downside risk	2.46	2.62	-0.15
Omega ratio Gain probability vs. loss probability	1.29	1.31	-0.02
Calmar ratio Return relative to maximum drawdown	0.14	-0.52	+0.67
Martin ratio Return relative to average drawdown	0.18	-0.61	+0.79
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

ULY vs. BIAF - Sharpe Ratio Comparison

The current ULY Sharpe Ratio is 0.06, which is higher than the BIAF Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of ULY and BIAF, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	ULY	BIAF	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.06	-0.13	+0.20
Sharpe Ratio (All Time) Calculated using the full available price history	-0.36	-0.30	-0.06

Correlation

The correlation between ULY and BIAF is 0.06, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

ULY vs. BIAF - Dividend Comparison

Neither ULY nor BIAF has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

ULY vs. BIAF - Drawdown Comparison

The maximum ULY drawdown since its inception was -97.43%, roughly equal to the maximum BIAF drawdown of -99.70%. Use the drawdown chart below to compare losses from any high point for ULY and BIAF.

Drawdown Indicators

	ULY	BIAF	Difference
Max Drawdown Largest peak-to-trough decline	-97.43%	-99.70%	+2.27%
Max Drawdown (1Y) Largest decline over 1 year	-88.19%	-97.71%	+9.52%
Current Drawdown Current decline from peak	-92.15%	-98.46%	+6.31%
Average Drawdown Average peak-to-trough decline	-80.77%	-83.60%	+2.83%
Ulcer Index Depth and duration of drawdowns from previous peaks	70.61%	83.66%	-13.05%

Volatility

ULY vs. BIAF - Volatility Comparison

The current volatility for Urgent.ly Inc. Common Stock (ULY) is 97.74%, while bioAffinity Technologies Inc. (BIAF) has a volatility of 104.73%. This indicates that ULY experiences smaller price fluctuations and is considered to be less risky than BIAF based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	ULY	BIAF	Difference
Volatility (1M) Calculated over the trailing 1-month period	97.74%	104.73%	-6.99%
Volatility (6M) Calculated over the trailing 6-month period	126.20%	130.79%	-4.59%
Volatility (1Y) Calculated over the trailing 1-year period	236.37%	383.26%	-146.89%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	179.54%	228.12%	-48.58%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	179.54%	228.12%	-48.58%

Financials